Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wir
DAK-Gesundheit awarded a contract of undisclosed value to OmniVision for Healthcare & Medical in May 2026 — one of 389 awards this buyer has made.
Buying agency
DAK-GesundheitWinning supplier
OmniVisionContract description
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Latanoprost (ausschließlich Einzeldosen), ATC S01EE01 für die Zeit 01.06.2025 - 31.05.2027
Related awards · DAK-Gesundheit
389 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-210283-2024Aktivital GmbH€9.1M10 Apr 2024 Healthcare
- ocds-ted-211590-2024Kraaibeek GmbH€2.5M10 Apr 2024 Healthcare
- ocds-ted-828775-2025news aktuell GmbH€38.0K12 Dec 2025 IT
Other wins · OmniVision
5 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-121733-2025-7GWQ ServicePlus AGNot disclosed24 Feb 2025 Healthcare
- ocds-ted-24679-2025-3IKK classicNot disclosed14 Jan 2025 Healthcare
- ocds-ted-633126-2025-4DAK-GesundheitNot disclosed29 Sep 2025 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for DAK-Gesundheit and OmniVision — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back